Cancer stem cells (CSCs) are responsible for therapeutic resistance and recurrence in
colorectal cancer. Despite advances in immunotherapy, the inability to specifically eradicate …

Dendritic cells (DCs) have been attracting attention in cancer immunotherapy because of
their role in inducing and modulating effective immune responses. Besides the direct contact …

Exosomes are vesicles that can be secreted by many types of cell and released into the
extracellular space. Studies have found that tumor derived exosomes (TEXs) can promote …

Dendritic cell-derived exosomes (Dex) have overcome the disadvantages associated with
dendritic cell (DC) vaccines, such as cost effectiveness, stability, and sensitivity to the …

Tumor cell-derived exosomes (TEX) have been widely used to induce antitumor immune
responses in animal models and clinical trials. However, the efficiency of the antitumor …

Cancer cells can secrete exosomes under various stressful conditions, whose functions are
involved in the delivery of various biologically active materials into host cells and/or …

Dendritic cells (DCs) are the most potent antigenpresenting cells in the human body. When
primed with antigens, DCs activate both helper and killer T cells and B cells. In the past …

Exosomes (EXO) derived from dendritic cells (DC), which express major histocompatibility
complex (MHC) and costimulatory molecules, have been used for antitumour vaccines …

Exosomes are nanoscale vesicles released by diverse types of cells for complex
intercellular communication. Numerous studies have shown that exosomes can regulate the …

Exosomes are nanovesicles originating from late endosomal compartments and secreted by
most living cells in ex vivo cell culture conditions. The interest in exosomes was rekindled …